HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

2 years ago

European Patent Allowed for Quantification by an ECG of Key Heart Measures using AISouthlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE)…

Odronextamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

2 years ago

TARRYTOWN, N.Y., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency…

Nemaura Medical Announces SFDA Approval of sugarBEAT®

2 years ago

Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology…

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors

2 years ago

CARLSBAD, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing…

SS Innovations Recognized on National News as India Celebrates Independence Day

2 years ago

News Channel, DD India, Features SS Innovations’ Work in the Field of Medical Technology as an Example of Indian Excellence…

Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification

2 years ago

Biostat STR(R) Bioreactor Biostat STR® now contains a fully compatible embedded XCell® ATF hardware and software moduleBioreactor and cell retention…

Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development

2 years ago

SAN MATEO, Calif. and CAMBRIDGE, Mass., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated…

The Shriners Hospitals for Children – Canada Research Centre celebrates half a century of existence

2 years ago

Its mission: To deliver the best treatments to children in Quebec and around the world 50th anniversary of the Shriners…

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

2 years ago

MINNEAPOLIS, MN, Aug. 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical…

Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

2 years ago

MALVERN, Pa., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (Nasdaq: BXRX), a biotechnology…